Revolutionary AI-driven therapeutic optimization system combining enhanced Nanotrol™ formulations with real-time biomarker analysis for breakthrough CRS management
Our proprietary platform represents the first AI-driven therapeutic optimization system specifically designed for Cytokine Release Syndrome management. By combining enhanced nanoformulated salsalate (Nanotrol™) with real-time biomarker analysis, we achieve unprecedented precision in CRS treatment.
The platform integrates machine learning algorithms that continuously analyze patient biomarkers including IL-6, IL-1β, TNF-α, and interferon-γ to optimize therapeutic selection and dosing in real-time, dramatically improving patient outcomes while reducing healthcare costs.
Our approach transforms CRS management from reactive treatment to proactive, personalized intervention, setting new standards for CAR-T therapy safety and efficacy.
Integrated platform combining AI optimization, enhanced formulations, and real-time analytics
Our proprietary nanoformulated salsalate represents a breakthrough in anti-inflammatory drug delivery. Through advanced nanotechnology, we've achieved 10x enhanced bioavailability compared to standard oral formulations, enabling effective intravenous administration for severe CRS cases where rapid intervention is critical.
Advanced lipid-based nanoparticles designed for optimal tissue penetration and cellular uptake
First-in-class IV formulation enabling rapid deployment in critical care settings
Improved half-life and tissue distribution compared to conventional formulations
Reduced systemic toxicity through targeted delivery and controlled release
Our machine learning platform analyzes real-time patient data to optimize therapeutic selection and dosing. The system processes multiple biomarker inputs, patient characteristics, and treatment responses to provide personalized recommendations that adapt as patient conditions evolve.
Advanced neural networks trained on comprehensive CRS patient datasets
Sub-second analysis and recommendation generation for critical care scenarios
Individual patient optimization based on genetics, biomarkers, and response patterns
System improves with each patient interaction through federated learning networks
Comprehensive biomarker analysis platform that continuously monitors key inflammatory markers to guide treatment decisions. Our system tracks IL-6, IL-1β, TNF-α, interferon-γ, and other critical cytokines to detect CRS onset and monitor treatment response.
Simultaneous monitoring of 15+ inflammatory biomarkers and cytokines
Rapid bedside analysis with results available within 30 minutes
Early warning systems to predict CRS severity before clinical symptoms appear
Seamless integration with hospital EHR systems and clinical workflows
Our comprehensive platform seamlessly integrates all components into a unified system that provides clinicians with actionable insights and automated treatment recommendations. The platform is designed for easy implementation in existing hospital infrastructure.
Scalable, secure cloud infrastructure with 99.9% uptime guarantee
Physician mobile app for real-time alerts and treatment recommendations
Enterprise-grade security with full HIPAA compliance and data encryption
RESTful APIs for seamless integration with existing hospital systems
Comprehensive patent protection covering platform technology, formulations, and AI algorithms
Core machine learning algorithms for real-time biomarker analysis and therapeutic selection optimization in CRS management.
Proprietary nanoparticle formulations enabling IV administration of salsalate with enhanced bioavailability and reduced toxicity.
Systems and methods for continuous monitoring and integration of inflammatory biomarkers in clinical decision-making algorithms.
Machine learning models for early prediction of CRS severity and treatment response optimization in CAR-T therapy patients.